Paul V Maier, insider filing for ISCO
Paul Maier V, reporting
ISCO
International Stem Cell CORP SEC filings
Every EDGAR filing for International Stem Cell CORP (ISCO), newest first, with AI summaries and stories.
- Ticker
- ISCO
- CIK
- 1355790
- Latest filing
- Sep 18
Next: 10-Q expected ~Nov 13 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4International Stem Cell CORPISCOLIVE ROUTINE4International Stem Cell CORPISCOLIVE Paul V Maier, insider filing for ISCO
Paul Maier V, reporting
ROUTINE144International Stem Cell CORPISCOLIVE Paul V Maier, planned sale of ISCO shares
Paul Maier V, reporting
ROUTINE8-KInternational Stem Cell CORPISCOLIVE NOTABLE10-QInternational Stem Cell CORPISCOLIVE ROUTINEDEF 14CInternational Stem Cell CORPISCOLIVE ROUTINEPRE 14CInternational Stem Cell CORPISCOLIVE ROUTINE8-KInternational Stem Cell CORPISCOLIVE ROUTINE4International Stem Cell CORPISCOLIVE 2 insider filings
Wright Don, insider filing for ISCO
Show all 2
- 4Insider filing for ISCO
- 4Insider filing for ISCO
Wright Don, reporting
ROUTINE8-KInternational Stem Cell CORPISCOLIVE NOTABLE10-QInternational Stem Cell CORPISCOLIVE ROUTINEARSInternational Stem Cell CORPISCOLIVE ROUTINEDEF 14AInternational Stem Cell CORPISCOLIVE NOTABLE10-KInternational Stem Cell CORPISCOLIVE ROUTINE8-KInternational Stem Cell CORPISCOLIVE International Stem Cell CORP reported: Submission of Matters to a Vote of Security Holders
- ITEM 5.07 Submission of Matters to a Vote of Security Holders
NOTABLE10-QInternational Stem Cell CORPISCOLIVE International Stem Cell CORP (ISCO) has filed its Q3 2025 Form 10-Q, providing investors with a detailed update on the company's financial performance and operational activities during the quarter.